To access this element change to forms mode OFF
Grant Award View - GA40794
Evaluating the effectiveness and safety of sodium selenate as a disease...
GA ID:
GA40794
Agency:
Department of Health and Aged Care
Approval Date:
29-Mar-2019
Publish Date:
26-Apr-2019
Category:
Medical Research
Grant Term:
1-Apr-2019 to 31-Mar-2024
Value (AUD):
$1,604,184.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health and Medical Research
Grant Program:
2018_MRFF Rare Cancers Rare Diseases, Unmet Need_commencing_2018
Grant Activity:
Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)
Purpose:
Behavioural variant Frontotemporal Dementia (bvFTD) affects younger people aged 45-65 years old. Personality changes and memory loss can be distressing to both patients and family. There is no cure and no approved disease modifying therapies currently available. This clinical trial will test the effectiveness of sodium selenate as a new treatment to reduce the progression of bvFTD in patients and potentially reduce economic costs, e.g. a reduction in healthcare use, residential and formal care.
GO ID:
GO Title:
Medical Research Future Fund Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity
Internal Reference ID:
MRF1170276
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA